Kristen Ambrose Sells $88.1K of Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Apr 27, 2022
Open-Market Net Sale · SEC Form 4
−$88,143
10b5-1 Plan
Equity position changed by -8.6%
Equity Position
3.5K sh
3,823 → 3,496
Equity Change
-8.6%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Kristen Ambrose CIK 0001856587 |
CAO
|
Kristen Ambrose at Vertex Pharmaceuticals Inc MA
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,978,865
More from this insider at Vertex Pharmaceuticals Inc MA
| 2026-09-01 | Award | — | View |
| 2026-03-02 | Sell | -$172,560 | View |
| 2026-02-26 | Sell | -$108,456 | View |
| 2026-02-19 | Sell | -$1,064,297 | View |
| 2026-02-18 | - | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1F2F3 | 2022-04-25 | S - Sale 10b5-1 | 60 D | $267.37 | -$16,042 | 3,763 | Direct |
| Common StockF1F2F4 | 2022-04-25 | S - Sale 10b5-1 | 80 D | $268.46 | -$21,477 | 3,683 | Direct |
| Common StockF1F2F5 | 2022-04-25 | S - Sale 10b5-1 | 83 D | $269.51 | -$22,369 | 3,600 | Direct |
| Common StockF1F2F6 | 2022-04-25 | S - Sale 10b5-1 | 104 D | $271.68 | -$28,255 | 3,496 | Direct |
Footnotes (6)
- F1
- Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. Show more
- F2
- Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Show more
- F3
- Open market sales reported on this line occurred at a weighted average price of $267.37 (range $266.86 to $267.85). Show more
- F4
- Open market sales reported on this line occurred at a weighted average price of $268.46 (range $268.05 to $268.86). Show more
- F5
- Open market sales reported on this line occurred at a weighted average price of $269.51 (range $269.12 to $269.90). Show more
- F6
- Open market sales reported on this line occurred at a weighted average price of $271.68 (range $271.25 to $272.23). Show more
Related filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0000899243-22-015762
API docs
View Original SEC Filing